421 related articles for article (PubMed ID: 37833928)
1. Involvement of Epithelial-Mesenchymal Transition (EMT) in Autoimmune Diseases.
Sarrand J; Soyfoo MS
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833928
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-17 and -22 synergy linking inflammation and EMT-dependent fibrosis in Sjögren's syndrome.
Sisto M; Lorusso L; Tamma R; Ingravallo G; Ribatti D; Lisi S
Clin Exp Immunol; 2019 Nov; 198(2):261-272. PubMed ID: 31165469
[TBL] [Abstract][Full Text] [Related]
3. Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: Opportunities and challenges.
Fang Y; Ni J; Wang YS; Zhao Y; Jiang LQ; Chen C; Zhang RD; Fang X; Wang P; Pan HF
Autoimmun Rev; 2023 Mar; 22(3):103260. PubMed ID: 36565798
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of particulate matter and substrate stiffness on epithelial-to-mesenchymal transition.
Barker TH; Dysart MM; Brown AC; Douglas AM; Fiore VF; Russell AG;
Res Rep Health Eff Inst; 2014 Nov; (182):3-41. PubMed ID: 25669020
[TBL] [Abstract][Full Text] [Related]
5. Biosemantics guided gene expression profiling of Sjögren's syndrome: a comparative analysis with systemic lupus erythematosus and rheumatoid arthritis.
Shah NR; Noll BD; Stevens CB; Brennan MT; Mougeot FB; Mougeot JC
Arthritis Res Ther; 2017 Aug; 19(1):192. PubMed ID: 28818099
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D and Autoimmune Rheumatic Diseases.
Athanassiou L; Kostoglou-Athanassiou I; Koutsilieris M; Shoenfeld Y
Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189455
[TBL] [Abstract][Full Text] [Related]
7. [Autoimmune thyroid disease and associated rheumatic disorders].
Kerimović-Morina D
Srp Arh Celok Lek; 2005 Oct; 133 Suppl 1():55-60. PubMed ID: 16405258
[TBL] [Abstract][Full Text] [Related]
8. Ocular microvascular damage in autoimmune rheumatic diseases: The pathophysiological role of the immune system.
Hysa E; Cutolo CA; Gotelli E; Paolino S; Cimmino MA; Pacini G; Pizzorni C; Sulli A; Smith V; Cutolo M
Autoimmun Rev; 2021 May; 20(5):102796. PubMed ID: 33722750
[TBL] [Abstract][Full Text] [Related]
9. What about glucocorticoids in primary Sjögren's syndrome?
Priori R; Mastromanno L; Izzo R
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):237-244. PubMed ID: 33095141
[TBL] [Abstract][Full Text] [Related]
10. A Summary on the Genetics of Systemic Lupus Erythematosus, Rheumatoid Arthritis, Systemic Sclerosis, and Sjögren's Syndrome.
Ortíz-Fernández L; Martín J; Alarcón-Riquelme ME
Clin Rev Allergy Immunol; 2023 Jun; 64(3):392-411. PubMed ID: 35749015
[TBL] [Abstract][Full Text] [Related]
11. Suspected inflammatory rheumatic diseases in patients presenting with skin rashes.
Alves F; Gonçalo M
Best Pract Res Clin Rheumatol; 2019 Aug; 33(4):101440. PubMed ID: 31585842
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study.
Park EH; Strand V; Oh YJ; Song YW; Lee EB
Arthritis Res Ther; 2019 Feb; 21(1):61. PubMed ID: 30770765
[TBL] [Abstract][Full Text] [Related]
13. [Rheumatic diseases and allergies, the duality of the immune system].
Sánchez-Zuno GA; Oregón-Romero E; Hernández-Bello J; González-Estevez G; Vargas-Rosales R; Muñoz-Valle JF
Rev Alerg Mex; 2021; 68(4):264-275. PubMed ID: 34904562
[TBL] [Abstract][Full Text] [Related]
14. Molecular Pathogenesis of Chlamydia Disease Complications: Epithelial-Mesenchymal Transition and Fibrosis.
Igietseme JU; Omosun Y; Nagy T; Stuchlik O; Reed MS; He Q; Partin J; Joseph K; Ellerson D; George Z; Goldstein J; Eko FO; Bandea C; Pohl J; Black CM
Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29084894
[TBL] [Abstract][Full Text] [Related]
15. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-13: A promising therapeutic target for autoimmune disease.
Mao YM; Zhao CN; Leng J; Leng RX; Ye DQ; Zheng SG; Pan HF
Cytokine Growth Factor Rev; 2019 Feb; 45():9-23. PubMed ID: 30581068
[TBL] [Abstract][Full Text] [Related]
17. SMADS-Mediate Molecular Mechanisms in Sjögren's Syndrome.
Sisto M; Ribatti D; Lisi S
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801157
[TBL] [Abstract][Full Text] [Related]
18. Serum 14-3-3η protein is associated with clinical and serologic features of Sjögren's syndrome in patients with systemic lupus erythematosus: a cross-sectional analysis.
Hammam N; Gamal NM; Elzohri MH; Elsonbaty AM; Rashed AM; Eldaly ZH; Tarik D; Gheita TA
Clin Rheumatol; 2020 Sep; 39(9):2603-2610. PubMed ID: 32206972
[TBL] [Abstract][Full Text] [Related]
19. Involvement of midkine in autoimmune and autoinflammatory diseases.
Aynacıoğlu AŞ; Bilir A; Tuna MY
Mod Rheumatol; 2019 Jul; 29(4):567-571. PubMed ID: 30217121
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to small nuclear ribonucleoproteins. A strong association between anti-SS-B(La), HLA-B8, and Sjögren's syndrome.
Whittingham S; Mackay IR; Tait BD
Aust N Z J Med; 1983 Dec; 13(6):565-70. PubMed ID: 6609699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
